Page last updated: 2024-11-02

piracetam and Squamous Cell Carcinoma of Head and Neck

piracetam has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"Initial seizure control with enteral levetiracetam was achieved, and when enteral and intravenous (i."5.43Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case report. ( Chambers, J; Foreman, E; Mason, LD; Wells, GH, 2016)
"Initial seizure control with enteral levetiracetam was achieved, and when enteral and intravenous (i."1.43Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case report. ( Chambers, J; Foreman, E; Mason, LD; Wells, GH, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wells, GH1
Mason, LD1
Foreman, E1
Chambers, J1

Other Studies

1 other study available for piracetam and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case report.
    Age and ageing, 2016, Volume: 45, Issue:2

    Topics: Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Carcinoma, Squamous Cell; Head and Neck Neoplas

2016